Eyebot gets a $ 20 million series A to increase to expand access to eye care

EyeA startup that offers a 90 -second vision test kiosk offered

The Startup based in Boston, founded in 2021, optimizes how people access the vision of care by eliminating traditional obstacles, such as quotation delays, limited accessibility, complex insurance requirements and costs.

Their kiosks, already found in shopping centers, universities, retail stores, pharmacies, grocery chains, schools and airports, offer a free vision of 90 seconds. According to the company, each test generates a recipe that is then reviewed and approved by the doctors of the eyes with a licensed, ensuring quick, convenient and reliable recipes.

The new financing, which takes Eyebot’s total financing to more than $ 30 million, occurs approximately one year after the startup raised its seed round in June 2024. Since then, the startup has conducted more than 45,000 free viewing tests and is on the way to deliver more than half a million annual, he says.

“From our seed round, the change has been dramatic. We have passed the association with some of the largest companies in the United States, launching quiosks throughout the country and delivering tens of thousands of vision tests,” said Matthias Hofmann, co -founder and Eyebot CEO, to TechCrunch. “The income is climbing and our team has doubled in size. The most important thing is that we have shown that the model works: people are using Eyebot, doctors are validating the results and retailers are excited about the traffic that leads.”

What distinguishes Eyebot, said Hofmann, is his combination of convenience and medical guarantee. Each test is reviewed by a doctor, and all recipes are broadcast under clinical supervision. If the test results indicate something unusual, patients are referred to comprehensive exams in person. That speed balance plus clinical supervision gains confidence, he says.

“In our locations of the shopping centers, we have seen a surprising absorption of parents with children,” said Hofmann. “They will stop between stores, they will try Eyebot, sometimes even while holding their children’s hands, and they will go with a recipe in just a couple of minutes.”

To convince traditional suppliers of eye care to adopt a first technological approach has been difficult. Early skepticism was deep: doctors concerned about precision, while patients questioned whether such a fast process could be reliable, according to Hofmann. He says that hesitation decreased once the suppliers learned that the experience of doctors review each result, many with more than a decade of experience.

Eyebot is in the early marketing phases. His vision test is offered for consumers, and if a recipe is needed, one of the company’s doctors verifies it by a rate. In addition, the company rents its kiosks to optical retailers, marks of independent glasses and practices.

With series A, the company plans to climb the deployment of the kiosk and expand its equipment in products, clinical operations and commercial growth, said the CEO.

The last round was directed by General Catalyst and included the participation of investors returning Alleycorp, Baukunst, Village Global, Humba Venture, Ravelin and Ubiquity Ventures.